Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
11 auth. P. Calabresi, B. Kieseier, D. Arnold, L. Balcer, A. Boyko, J. Pelletier, ... Shifang Liu, Ying Zhu, A. Seddighzadeh, S. Hung, A. Deykin